A career-changer's intensive into pharmaceutical regulatory affairs — built for working pharmacists who want out of retail and into industry. Six weeks. Twice-weekly evenings. A real eCTD dossier in your portfolio, and introductions to RA hiring managers across our network.
You went to pharmacy school for the science — and you're now counting pills behind a counter. The career you actually trained for is in industry: drug development, regulatory affairs, market access. RA roles in the GCC pay 30–50% more than retail and are growing faster than they can be filled. The hardest part isn't competing for the job — it's getting your foot in the door without industry experience. That's exactly what we solve.
You don't want to spend three years stuck in retail before someone takes a chance on you. Pharma Pivot gets you into industry directly — with a real dossier portfolio and the hiring network introductions that turn applications into interviews.
The program also works for working RA officers wanting structured exposure to GCC-specific submissions, the latest SFDA and MOHAP guidance, and the eCTD lifecycle — but it's designed around career-changers first.
We run private corporate cohorts for pharma companies and CROs onboarding new RA staff. Custom curriculum to your portfolio and target markets. Talk to us about a private cohort →
Six weeks. Two evenings a week. One Dubai weekend at the midpoint. That's it.
We designed Pharma Pivot so you can keep your current shifts at the pharmacy while you train for what's next — no need to quit your job before you have somewhere to land. Tuesday and Thursday evenings from 7–9pm GST, plus one in-person weekend in Dubai at the program's halfway point where the cohort meets, works through case studies together, and starts the dossier capstone.
Most other RA programs in the region run on weekday daytime hours or Sunday mornings — schedules that assume you're not working. We don't assume that. We built around the pharmacist who's actually trying to make the switch.
Most regulatory affairs courses give you a certificate. We give you something hiring managers actually want to see.
By the end of week six, every Pharma Pivot graduate has built a complete, real eCTD dossier — full Modules 1 through 5, structured around a published medicine, ready to walk into any interview with. RA hiring managers tell us the same thing: candidates show up with certifications and theory, but almost none show up with portfolio evidence that they've actually done the work.
Your capstone is reviewed by our practising RA faculty, refined over the final two weeks, and becomes the centerpiece of how you present yourself to prospective employers. Combined with the interview-prep workshop in the final session, you don't just leave with a credential — you leave ready to perform in the interview that matters.
This is the differentiator. Anyone can teach the framework. We make sure you walk out with the artifact.
We don't promise jobs. We promise introductions.
Our hiring partner network includes regulatory teams at multinational pharma operating in the GCC, regional pharma manufacturers, CROs, medical device companies, and pharmaceutical distributors across UAE and KSA. When the right opportunity matches the right graduate, we make the warm introduction.
What this means in practice: graduates of Pharma Pivot go into the program's final two weeks knowing which roles are likely to be open in our network, get coached on the specific companies hiring, and leave with concrete next steps — not a generic certificate and a hope.
No graduate of Pharma Pivot has ever needed to apply to RA roles cold. We don't think you should have to either.
Compressed and focused. We cut the academic survey content that traditional 3-month programs include and built around the modules that actually matter for breaking into industry. Every week pairs technical depth with applied work on your capstone dossier.
The role of regulatory affairs in pharma, the global regulatory landscape, ICH guidelines, and how RA functions actually fit into a pharma company day-to-day.
SFDA (Saudi Arabia), MOHAP & EDE (UAE), SCH (Kuwait), MOPH (Qatar), NHRA (Bahrain), MOH (Oman) — structures, jurisdictions, and how decisions actually get made.
Module 1–5 architecture, content requirements, GCC-specific Module 1 expectations, and how reviewers actually read submissions. Capstone work begins.
The transition to eCTD across GCC markets, technical requirements, validation tools, lifecycle management, and the publishing software landscape.
Module 3 in depth — drug substance, drug product, manufacturing process, specifications, stability data, and the most common quality deficiencies.
Modules 4 and 5 essentials — study reports, summary documents, and the bridging studies that GCC submissions sometimes need.
Bioequivalence requirements, biosimilar pathways, GCC-specific stance on each — including current SFDA priorities. In-person Dubai weekend at the midpoint.
Variations (Type IA, IB, II), renewals, line extensions, and how to plan a multi-year regulatory strategy that doesn't lose authorisations through neglect.
GMP framework, GCC inspection programmes, mock audits, and how to prepare a manufacturing site for an SFDA or MOHAP inspection.
The PV system, qualified person responsibilities (QPPV), adverse event reporting, signal detection, GCC-specific PV requirements and PSURs.
Faculty review your complete eCTD dossier. Refinement, feedback, and finalization. You walk out with portfolio-ready evidence of your work.
How RA interviews actually work in the GCC. Common questions, how to talk about your dossier, what hiring managers look for. Plus: introductions begin.
The pharmacists who make the switch into industry aren't the most talented ones — they're the ones who got the right break at the right time. We're trying to manufacture more of those breaks.
— Lead instructor
Most regional RA programs are three months long, run on academic schedules, and end with a certificate. Pharma Pivot is six weeks, runs on evenings, and ends with a real dossier and introductions. Built specifically for working pharmacists trying to make the move.
Six weeks instead of three months. We cut the academic survey content and built around the modules that actually matter for breaking into industry.
Tue + Thu evenings, 7–9pm GST. You can keep your current shifts while you train. No need to quit before you have somewhere to land.
A complete eCTD dossier you walk out with. Faculty-reviewed, interview-ready. Almost no other candidate brings this to an interview — you will.
We don't promise jobs — we promise introductions. Our network includes regulatory teams across multinational and regional pharma in the GCC.
If your question isn't here, talk to an advisor — fifteen minutes, no commitment. We'll give you a straight answer about whether this program is the right fit for where you are right now.
Six weeks from now you can be in industry — with a real dossier, a hiring network, and a career that pays you for what you actually trained for. Talk to an advisor or reserve your seat in the June cohort.
Reserve your seat